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This outline is intended to list the essential elements for surveillance of healthcare-associated 
infections (HAI) and succinctly describe the traditional surveillance methodology that has been 
used in HAI surveillance systems conducted by the Centers for Disease Control and 
Prevention since 1970, i.e., the National Nosocomial Infections Surveillance (NNIS) System 
and the National Healthcare Safety Network (NHSN).  Numerator and denominator data to 
collect and their sources are also described, as is how an infection control professional (ICP) 
collects such data. References to more detailed accounts of HAI surveillance are provided. 
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I. Essential Elements of Surveillance1, 2, 3 
A. Assess the population and identify those at greatest risk for the outcome or 
process of interest 
1. Healthcare-associated infections (HAI) (outcomes) 
2. Patient care practices aimed at preventing HAI (processes) 
B. Select the outcome or process for surveillance 
1. Examples of outcomes: HAI, infection or colonization with a specific 
organism, pyrogenic reaction or vascular access infection in hemodialysis 
patients, sharps injuries, etc. 
2. Examples of processes: Central line insertion practices (CLIPs), surgical care 
processes (e.g., preoperative antimicrobial prophylaxis), medication errors, 
influenza vaccination rates, hepatitis B immunity rates, personnel compliance 
with protocols, etc. 
3. Examples of other events: Occurrence of reportable diseases and conditions,
communicable diseases in personnel, organisms or syndromes indicative of 
bioterrorist events, etc. 
C. Determine observation time period 
D. Choose the surveillance methodology (See Section II) 
E. Monitor for the outcome or process using standardized definitions for all data 
collected 
F. Collect appropriate denominator data, if rates are to be calculated 
G. Analyze surveillance data 
H. Report and use surveillance information in a timely manner 
II. Surveillance Methodology1, 4, 5 
Routine HAI surveillance in most in-patient healthcare facilities should be conducted by an 
infection control professional (ICP) in an active, patient-based, prospective, priority-directed 
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manner that yields risk-adjusted incidence rates, as defined below.  This methodology will be 
most useful for the detection of endemic HAI, rather than for outbreak detection.   
A. Active and passive 
1. Active surveillance 
a) Trained personnel, mainly ICPs, vigorously look for HAI  
b) Information accumulated by using a variety of data sources within and 
beyond the nursing ward (See Section IIIB and IVB) 
2. Passive surveillance 
a) Persons who do not have a primary surveillance role, such as ward 
nurses or respiratory therapists, identify and report HAI 
B. Patient-based and laboratory-based 
1. Patient-based 
a) Count HAI, assess risk factors, and monitor patient care procedures 
and practices for adherence to infection control principles 
b) Requires ward rounds and discussion with caregivers 
2. Laboratory-based 
a) Detection is based solely on the findings of laboratory studies of 
clinical specimens 
C. Prospective and retrospective 
1. Prospective surveillance 
a) Monitor patients during their hospitalization 
b) For SSIs, also monitor during the post-discharge period 
2. Retrospective surveillance 
a) Identify infections via chart reviews after patient discharge 
D. Priority-directed and comprehensive 
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1. Priority-directed (also called targeted, focused, or Surveillance by Objective)6 
a) Objectives for surveillance are defined 
b) Focus is on specific events, processes, organisms, and/or patient 
populations
2. Comprehensive 
a) Continuous monitoring of all patients for all events and/or processes 
b) Highly personnel resource intensive if done manually 
E. Risk-adjusted rates and crude rates 
1. Risk-adjusted rates 
a) Rates are controlled for variations in the distribution of major risk 
factors associated with an event’s occurrence 
b) Such rates allow inter- and intra-facility rate comparisons 
2. Crude rates 
a) Rates assume equal distribution of risk factors for all events 
b) Such rates cannot be used for inter-facility comparisons 
F. Incidence and prevalence 
1. Incidence 
a) Count only new events occurring during some defined time period 
2. Prevalence 
a) Count all events (new and previously existing) occurring at either a 
point in time or during some defined time period 
III.  Numerator Data Collection1, 4, 5, 7 
Personnel other than ICPs may be trained to screen data sources for HAI, or automated 
screening of electronic databases may be used, as long as the ICP makes the final 
determination of presence of HAI according to the criteria for defining HAI. 
4
 
  
 
  
A. Numerator data to collect 
1. Demographic – name, date of birth, gender, hospital identification number, 
admission date 
2. Infection – onset date, site of infection, patient care location of HAI onset 
3. Risk factors – devices, procedures, other factors associated with HAI 
4. Laboratory – pathogens, antibiogram, serology, pathology 
5. Radiology/imaging – X-ray, CT scan, MRI, etc. 
B. Sources of numerator data 
1. Admission/discharge/transfer records, microbiology laboratory records 
2. Visits to patient wards for observation and discussion with caregivers 
3. Patient charts (paper or computerized) for case confirmation 

a) Laboratory and radiology/imaging results 

b) Nursing and physician’s notes and consults 

c) Admission diagnosis 

d) History and physical examination findings 

e) Records of diagnostic and surgical interventions 

f) Temperature chart 

g) Information on administration of antibiotics 

4. For post-discharge detected SSI, sources include records from surgery 
clinics, physician’s offices, emergency departments8 
C. How an ICP collects numerator data 
1. Screens admission/discharge/transfer records for patients admitted with 
infection and those whose diagnoses put them at risk of acquiring HAI 
2. Reviews laboratory reports looking for patients with possible infections (e.g., 
positive microbiology cultures, positive pathology findings) and converses with 
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laboratory personnel trying to identify patients that might be infected and to 
identify clusters of infections, especially in areas not targeted for routine HAI 
surveillance 
3. During ward rounds, quickly screens nursing care reports, temperature 
charts, antibiotic administration sheets, and Kardexes; converses with nurses 
and physicians trying to identify patients who might be infected 
4. Performs chart review of patients suspected of having HAI: reviews 
physician’s progress notes and nurse’s notes, laboratory data, radiology/imaging 
reports, surgery reports, etc.; if electronic charts are available, these can be 
reviewed from the ICP’s desk, but ward rounds are still essential for surveillance, 
prevention, and control activities 
5. Completes HAI data collection forms/screens as data sources are reviewed 
IV. Denominator Data Collection1, 4, 5, 7 
Denominator data may be collected by someone other than the ICP as long as that person  is 
trained. When denominator data are available from electronic databases (e.g., patient tracking 
systems, respiratory therapy database), these sources may be used as long as the counts are 
not substantially different from those collected manually. 
A. Denominator data to collect 
1. Counts of the cohorts of patients at risk of acquiring HAI 
2. For device-associated HAI incidence density rates9: record daily the total 
number of patients and total number of ventilator-days, central line-days, and 
urinary catheter-days in the patient care area(s) under surveillance; sum these 
daily counts at the end of the surveillance period for use as denominators 
3. For SSI rates stratified by the NNIS basic or modified risk index9:  record 
information on operative procedures selected for surveillance (e.g., type of 
procedure, date, risk factors, etc.) 
B. Sources of denominator data 
1. For device-associated incidence density rates: visits to patient care areas to 
obtain daily counts of the number of patients admitted and the number of patients 
with each of the commonly used devices associated with HAI (i.e., one or more 
central line, ventilator, or indwelling urinary catheter) 
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2. For SSI rates: detailed logs from the operating room for each operative 
procedure 
C. How an ICP collects denominator data 
1. For device-associated incidence density rates: records daily counts of the 
number of patients admitted and the number of patients with each of the 
commonly used devices associated with HAI (i.e., one or more central line, 
ventilator, or indwelling urinary catheter) 
2. For SSI rates: obtains data on operations from operating room logs and 
patient charts as needed 
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